Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common di…
$3.60+3.15%
报价 2026-11-06
市值
$44.5M
EV
$49.8M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -42.7%
$3.27$6.28
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| NMADNOMAD Power Solutions, Inc. | $44.5M | +3.2% | – | 0% | – | – | – | |
| IMAImageneBio Inc | $46.6M | -1.4% | 0.0% | 0% | – | – | – | |
| TILInstil Bio, Inc. | $46.3M | -2.3% | +2.6% | 0% | – | – | – | |
| CNTBConnect Biopharma Holdings Limited | $45.9M | -0.4% | – | 100% | – | – | – | |
| MREOMereo BioPharma Group plc | $45.2M | +0.9% | – | 0% | – | – | – | |
| ATNMActinium Pharmaceuticals, Inc. | $45M | +10.0% | +12800.0% | 101.1% | 4.0x | 0.8x | – | |
| TENXTenax Therapeutics, Inc. | $44.8M | +3.7% | +110.0% | 0% | – | – | – | |
| ONCYOncolytics Biotech Inc. | $44.1M | -2.1% | – | 0% | – | – | – | |
| GANXGain Therapeutics, Inc. | $43.9M | +7.2% | – | 0% | – | – | – | |
| 同行中位数 | – | – | +56.3% | 0% | 4.0x | 0.8x | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。